- Home
- SATX vs NVCT Comparison
SATX vs NVCT Comparison
Compare SATX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATX
- NVCT
- Stock Information
- Founded
- SATX 2012
- NVCT 2020
- Country
- SATX Israel
- NVCT United States
- Employees
- SATX N/A
- NVCT N/A
- Industry
- SATX Radio And Television Broadcasting And Communications Equipment
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SATX Technology
- NVCT Health Care
- Exchange
- SATX Nasdaq
- NVCT Nasdaq
- Market Cap
- SATX 130.6M
- NVCT 107.8M
- IPO Year
- SATX N/A
- NVCT 2022
- Fundamental
- Price
- SATX $1.42
- NVCT $5.49
- Analyst Decision
- SATX Strong Buy
- NVCT Strong Buy
- Analyst Count
- SATX 2
- NVCT 1
- Target Price
- SATX $2.25
- NVCT $21.00
- AVG Volume (30 Days)
- SATX 461.3K
- NVCT 104.2K
- Earning Date
- SATX 02-14-2025
- NVCT 03-04-2025
- Dividend Yield
- SATX N/A
- NVCT N/A
- EPS Growth
- SATX N/A
- NVCT N/A
- EPS
- SATX N/A
- NVCT N/A
- Revenue
- SATX $10,351,000.00
- NVCT N/A
- Revenue This Year
- SATX $80.62
- NVCT N/A
- Revenue Next Year
- SATX N/A
- NVCT N/A
- P/E Ratio
- SATX N/A
- NVCT N/A
- Revenue Growth
- SATX N/A
- NVCT N/A
- 52 Week Low
- SATX $0.30
- NVCT $4.44
- 52 Week High
- SATX $2.39
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- SATX 52.30
- NVCT 49.57
- Support Level
- SATX $1.21
- NVCT $5.34
- Resistance Level
- SATX $1.57
- NVCT $5.89
- Average True Range (ATR)
- SATX 0.33
- NVCT 0.51
- MACD
- SATX -0.04
- NVCT 0.02
- Stochastic Oscillator
- SATX 23.02
- NVCT 33.68
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.